Bank of New York Mellon’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $63.2M | Sell |
3,239,486
-61,653
| -2% | -$1.22M | 0.01% | 928 |
|
|
2026
Q1 | $63.5M | Sell |
3,301,139
-38,106
| -1% | -$751K | 0.01% | 857 |
|
|
2025
Q4 | $63.2M | Sell |
3,339,245
-700,210
| -17% | -$13M | 0.01% | 865 |
|
|
2025
Q3 | $75.3M | Sell |
4,039,455
-135,603
| -3% | -$2.53M | 0.01% | 783 |
|
|
2025
Q2 | $77M | Buy |
4,175,058
+60,843
| +1% | +$1.08M | 0.01% | 740 |
|
|
2025
Q1 | $71.9M | Buy |
4,114,215
+74,564
| +2% | +$1.26M | 0.01% | 761 |
|
|
2024
Q4 | $70M | Buy |
4,039,651
+463,601
| +13% | +$8.47M | 0.01% | 812 |
|
|
2024
Q3 | $66.6M | Sell |
3,576,050
-608,842
| -15% | -$10.3M | 0.01% | 845 |
|
|
2024
Q2 | $64.4M | Sell |
4,184,892
-97,116
| -2% | -$1.39M | 0.01% | 868 |
|
|
2024
Q1 | $63.2M | Sell |
4,282,008
-168,541
| -4% | -$2.33M | 0.01% | 907 |
|
|
2023
Q4 | $63.5M | Sell |
4,450,549
-475,795
| -10% | -$6.76M | 0.01% | 897 |
|
|
2023
Q3 | $68.7M | Sell |
4,926,344
-499,601
| -9% | -$6.39M | 0.02% | 806 |
|
|
2023
Q2 | $63.9M | Sell |
5,425,945
-168,887
| -3% | -$1.92M | 0.01% | 875 |
|
|
2023
Q1 | $64.3M | Buy |
5,594,832
+689,809
| +14% | +$8.53M | 0.01% | 856 |
|
|
2022
Q4 | $61M | Buy |
4,905,023
+1,340,541
| +38% | +$17.1M | 0.01% | 870 |
|
|
2022
Q3 | $46.8M | Sell |
3,564,482
-586,747
| -14% | -$8.67M | 0.01% | 1005 |
|
|
2022
Q2 | $58M | Sell |
4,151,229
-320,441
| -7% | -$4.28M | 0.01% | 892 |
|
|
2022
Q1 | $66.6M | Sell |
4,471,670
-111,060
| -2% | -$1.52M | 0.01% | 907 |
|
|
2021
Q4 | $62M | Sell |
4,582,730
-901,561
| -16% | -$12.8M | 0.01% | 1007 |
|
|
2021
Q3 | $80.7M | Sell |
5,484,291
-334,587
| -6% | -$5.65M | 0.02% | 807 |
|
|
2021
Q2 | $106M | Sell |
5,818,878
-289,127
| -5% | -$5.15M | 0.02% | 685 |
|
|
2021
Q1 | $106M | Sell |
6,108,005
-626,067
| -9% | -$11M | 0.02% | 670 |
|
|
2020
Q4 | $117M | Sell |
6,734,072
-756,284
| -10% | -$12.1M | 0.03% | 590 |
|
|
2020
Q3 | $103M | Buy |
7,490,356
+51,890
| +0.7% | +$762K | 0.03% | 560 |
|
|
2020
Q2 | $107M | Buy |
7,438,466
+631,172
| +9% | +$8.3M | 0.03% | 514 |
|
|
2020
Q1 | $74.3M | Buy |
6,807,294
+1,916,219
| +39% | +$35.3M | 0.02% | 576 |
|
|
2019
Q4 | $104M | Buy |
4,891,075
+1,325,961
| +37% | +$29.7M | 0.03% | 585 |
|
|
2019
Q3 | $81.9M | Buy |
3,565,114
+86,313
| +2% | +$1.84M | 0.02% | 674 |
|
|
2019
Q2 | $68.5M | Buy |
3,478,801
+358,924
| +12% | +$6.99M | 0.02% | 782 |
|
|
2019
Q1 | $60.7M | Buy |
3,119,877
+484,377
| +18% | +$9.18M | 0.02% | 842 |
|
|
2018
Q4 | $43.4M | Sell |
2,635,500
-17,163
| -0.6% | -$346K | 0.01% | 987 |
|
|
2018
Q3 | $61.3M | Sell |
2,652,663
-11,046
| -0.4% | -$250K | 0.02% | 882 |
|
|
2018
Q2 | $57.9M | Buy |
2,663,709
+12,607
| +0.5% | +$246K | 0.02% | 907 |
|
|
2018
Q1 | $46.8M | Sell |
2,651,102
-10,835
| -0.4% | -$191K | 0.01% | 1050 |
|
|
2017
Q4 | $50M | Sell |
2,661,937
-2,059,366
| -44% | -$41M | 0.01% | 1019 |
|
|
2017
Q3 | $104M | Buy |
4,721,303
+3,523,631
| +294% | +$79.6M | 0.03% | 591 |
|
|
2017
Q2 | $28.9M | Sell |
1,197,672
-69,991
| -6% | -$1.78M | 0.01% | 1324 |
|
|
2017
Q1 | $35.4M | Buy |
1,267,663
+23,747
| +2% | +$623K | 0.01% | 1194 |
|
|
2016
Q4 | $30.4M | Buy |
1,243,916
+45,738
| +4% | +$1.05M | 0.01% | 1269 |
|
|
2016
Q3 | $30.2M | Buy |
1,198,178
+244,614
| +26% | +$5.86M | 0.01% | 1188 |
|
|
2016
Q2 | $19.7M | Sell |
953,564
-97,937
| -9% | -$2.04M | 0.01% | 1409 |
|
|
2016
Q1 | $21.1M | Buy |
1,051,501
+89,213
| +9% | +$1.71M | 0.01% | 1371 |
|
|
2015
Q4 | $19.5M | Buy |
962,288
+96,580
| +11% | +$2.03M | 0.01% | 1407 |
|
|
2015
Q3 | $20.1M | Buy |
865,708
+161,044
| +23% | +$4.11M | 0.01% | 1406 |
|
|
2015
Q2 | $18.1M | Buy |
704,664
+38,646
| +6% | +$1.1M | 0.01% | 1554 |
|
|
2015
Q1 | $22.1M | Buy |
666,018
+59,695
| +10% | +$1.94M | 0.01% | 1428 |
|
|
2014
Q4 | $18.4M | Buy |
606,323
+66,590
| +12% | +$1.84M | ﹤0.01% | 1529 |
|
|
2014
Q3 | $13.1M | Sell |
539,733
-1,075,508
| -67% | -$29.8M | ﹤0.01% | 1731 |
|
|
2014
Q2 | $46.4M | Buy |
1,615,241
+1,134,111
| +236% | +$33M | 0.01% | 951 |
|
|
2014
Q1 | $13.4M | Buy |
481,130
+11,286
| +2% | +$310K | ﹤0.01% | 1713 |
|
|
2013
Q4 | $12.3M | Sell |
469,844
-130,584
| -22% | -$3.37M | ﹤0.01% | 1756 |
|
|
2013
Q3 | $13.8M | Buy |
600,428
+14,450
| +2% | +$356K | ﹤0.01% | 1639 |
|
|
2013
Q2 | $15.3M | Buy |
+585,978
| New | +$16.9M | ﹤0.01% | 1551 |
|
Other funds holding SBRA
CIM
N
LIMS
DPIM
Bank of New York Mellon's SBRA Position: Q2 2026 in Review
Bank of New York Mellon reduced its Sabra Healthcare REIT (SBRA) stake by 1.9% in Q2 2026, selling an estimated $1.22M and leaving 3,239,486 shares worth $63.2M. The position accounts for 0.01% of the portfolio, ranked #928.
Bank of New York Mellon first reported a position in SBRA in Q2 2013 and has held it in 53 quarters since. The position peaked at $117M in Q4 2020. 280 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.
- Bank of New York Mellon held 3,239,486 shares of Sabra Healthcare REIT worth $63.2M as of Q2 2026.
- Bank of New York Mellon sold 61,653 Sabra Healthcare REIT shares in Q2 2026, an estimated $1.22M.
- Sabra Healthcare REIT made up 0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #928 holding.
- Bank of New York Mellon first reported a position in Sabra Healthcare REIT in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Sabra Healthcare REIT position peaked at $117M in Q4 2020.
- 280 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.